Current through Register Vol. 43, No. 02, November 27, 2024
Section 420-3-23-.05 - Client Information And Site Care Information(1) Information given prior to a procedure - (a) Body art facilities shall prominently display a Disclosure Statement which advises the public of the risks and possible consequences of body art services. The Disclosure Statement shall be posted in a conspicuous place in the facility's waiting or general public area, and easily seen by potential clients wanting to receive a body art procedure.(b) The Disclosure Statement shall include, at a minimum, the following wording in bold type: 1. "There may be risks associated with the procedures of commercial body art which includes permanent tattoos, body piercing and permanent cosmetic application, that may adversely affect the healing process, or may be a concern due to potential disease transmission, if you have, or have had, any of the following conditions: (i) History of Hepatitis B or Hepatitis C;(iv) History of hemophilia or any other blood disorder/disease;(v) History of skin diseases or skin lesions;(vi) History of sensitivities to soaps, disinfectants, etc.;(vii) History of allergies or adverse reactions to pigments, dyes, latex, etc.;(x) History of epilepsy, seizures, fainting, or narcolepsy;(xii) History of heart murmur or any heart disease/condition;(xiii) History of taking medications such as anticoagulants that thin the blood and/or interferes with blood clotting;(xiv) Pregnancy or breast feeding/nursing."(c) In the event a body piercing procedure is to be performed which involves the oral area ("oral piercing"), the client should be given oral piercing information such as shown in Appendix C.(2) Site care information - A written information sheet, shown in Appendix D, with instructions for general site care which shall be provided as a minimum to each client. The facility may provide additional information as it deems appropriate. The body art procedure site care information shall be provided to each client by the operator upon completion of the procedure. The written information sheet shall also contain the name, address and phone number of the body art facility. (b) The written information shall advise the client to consult a physician at the first sign of infection; such as redness, swelling, drainage, prolonged pain at the body art procedure site, or onset of fever.(3) Reporting known infections, complications, or diseases required - A person who owns or operates a licensed tattoo facility shall, within 24 hours of becoming aware that an individual tattooed, branded, or body pierced at the tattoo facility is infected with a communicable disease, notify the department or a local county health department. Authors: Ronald Dawsey, Charlotte Denton
Ala. Admin. Code r. 420-3-23-.05
New Rule: Filed March 15, 2001; effective April 19, 2001; operative May 4, 2001. Repealed and New Rule: Filed December 20, 2006; effective January 24, 2007.Statutory Authority:Code of Ala. 1975, § 22-17A-7.